UPClytics
Alle Fälle anzeigen

UPC CFI 629/2026

30. Okt. 2025·EP3107487 · TEXTURED SURFACES FOR BREAST IMPLANTS

Verfahrensdetails
Status
Interim Phase
Verfahrensart
Widerklage auf Nichtigkeit
Kategorie
Widerklage auf Nichtigkeit
Division
Brussels LD
Technologie
  • Instruments
    Medical technology
  • Chemistry
    Micro-structural and nano-technology
Sprache
English
Erste Entscheidung
18. März 2026
Letzte Entscheidung
14. Aug. 2026
Im Vergleich
Die Bilanz des Gerichts für diese Art von Verfahren, gezählt in erstinstanzlichen Entscheidungen. Eine Zahl in Klammern gibt an, auf wie vielen Entscheidungen eine Quote beruht.
Patent nichtigMedian Tage bis zur ersten Entscheidung
Gesamt-UPC37% (34/91)124
Brussels LD—Gesperrt
Richter Samuel GranataGesperrtGesperrt
Richter Carine GilletGesperrtGesperrt
Richter Marije KnijffGesperrtGesperrt
Richter Paolo Gerli—Gesperrt

Vor dem UPC: GC Aesthetics ParentCo Limited (2 Verfahren)·Establishment Labs S.A. (3 Verfahren)

Entscheidungen
  • 2026-08-14
    Counter claim for revocationÖffentlich

    Zusammenfassung: Procedural order under R. 9 and R. 36 RoP holding the 'Infringement' and 'Relief' sections of LABS's rejoinder (other than paragraphs 611 to 616) inadmissible and excluding them, while allowing the 'Acts of Infringement' and 'Jurisdiction' sections, ordering a revised rejoinder within 16 days and extending the defendants' further pleadings deadline to 7 September 2026.

    Rechtsfragen anzeigen (2)
    • further written pleadings (R. 36 RoP)
    • admissibility of rejoinder sections
  • 2026-06-26
    Counterclaim for revocationÖffentlich

    Zusammenfassung: The Brussels Local Division issued Order II under R.190 RoP, ordering Establishment Labs S.A. to produce evidence to the GC Aesthetics Defendants under Categories B, C, and D, timed to align with the parallel UK High Court disclosure order of 23 June 2026. The Court coordinated evidence production between UPC and UK proceedings in the interest of procedural efficiency and proportionality.

    Rechtsfragen anzeigen (4)
    • Application to produce evidence under R.190 RoP
    • Alignment of parallel national (UK) and UPC evidence production proceedings
    • Proportionality of evidence requests
    • Coordination with UK High Court disclosure proceedings (HP-2026-000009)
  • 2026-06-04
    Counterclaim for revocationÖffentlich

    Zusammenfassung: The Brussels Local Division granted the claimant ESTABLISHMENT LABS leave under R.263.3 RoP to limit its infringement claim by withdrawing the UK portion against Defendants 1, 2, 4 and 10. The Court held that Defendants 2 and 10 have no legal basis remaining in the infringement action but ordered them to remain parties for costs purposes, and granted leave to appeal.

    Rechtsfragen anzeigen (4)
    • Leave to limit claim unconditionally under R.263.3 RoP
    • Interaction between R.263.3 and R.265 RoP: whether limiting an action automatically triggers R.265 RoP
    • Application of R.361 RoP: manifestly bound to fail / manifestly inadmissible
    • Costs consequences for defendants no longer pursued in infringement action
  • 2026-04-14
    Infringement ActionÖffentlich

    Zusammenfassung: The Brussels Local Division granted Defendants' R.190 RoP application for production of evidence (sales figures, physical samples, promotional materials, third-party test reports, technical specifications, performance qualification reports, regulatory documentation, and Design History File) relating to LABS's Motiva SilkSurface breast implants, while denying the request for post-priority-date physical samples (request I.c). Production is subject to a tiered compliance mechanism whereby if LABS provides pre-priority physical samples and declares prior public availability, the remaining documentary requests are waived; LABS is also ordered to pay a recurring penalty of EUR 2,000 per day of non-compliance.

    Rechtsfragen anzeigen (8)
    • Application to produce evidence under R.190 RoP / Art. 59 UPCA
    • Conditions for evidence production order: reasonable available evidence, specification and control, confidentiality, proportionality
    • Prior art anticipation (lack of novelty / inventive step) by Motiva SilkSurface pre-priority product
    • Unusual surface topography parameters (Sa, Ssk, Sz) at non-standard area scales
    • Premature timing of evidence production application
    • Proportionality and burden of evidence production
    • Confidentiality protection under R.262A RoP
    • Recurring penalty payments under Art. 82(4) UPCA and R.354.3 RoP
  • 2026-03-18

    Zusammenfassung: Brussels Local Division ordered Establishment Labs SA to provide security for costs of EUR 600,000 within 21 days in both UPC_CFI_1357/2025 and UPC_CFI_629/2026 proceedings concerning EP 3 107 487 B1. The Court held that the claimant's non-EU incorporation (Costa Rica) and concerns about recoverability of a cost order justified the security requirement, rejecting other elements of the defendants' R. 158 application.

    Rechtsfragen anzeigen (4)
    • Security for costs (R. 158 RoP, Art. 69(1) UPCA)
    • Non-EU claimant enforcement risk
    • Undue burden of enforcement
    • Witness statement (R. 175.2 RoP)
DokumenttitelDatumÖffentlich
Mitteilung2026-10-16Nicht öffentlich
Receipt2026-10-16Nicht öffentlich
Cover sheet2026-10-16Nicht öffentlich
Document2026-10-16Nicht öffentlich
Receipt2026-10-13Nicht öffentlich
Cover sheet2026-10-13Nicht öffentlich
Receipt2026-10-13Nicht öffentlich
Cover sheet2026-10-13Nicht öffentlich
Document Defendant2026-10-13Nicht öffentlich
Document Defendant2026-10-13Nicht öffentlich
Angenommene Argumente
Was das Gericht akzeptiert hat — nach Partei.
  • R.190 RoP application was not premature as the facts to be proven were clearly identified and LABS disputed the underlying assertions, satisfying condition 4(a) on proportionality/timing

    KlägerRechtsgrundlage: Art. 59 UPCA; R.190 RoP; CoA UPC_CoA_298,299,300/2024 (Guangdong v Panasonic)
  • Defendants presented reasonably available evidence (sales data, marketing brochures, SEC filings, post-published scientific studies) to prima facie support assertions that Motiva SilkSurface was publicly available before the priority date and that its surface parameters fell within the patent claims

    KlägerRechtsgrundlage: Art. 59 UPCA; R.190 RoP; R.172 RoP
  • Requested documentary evidence (sales figures, promotional materials, test reports, technical specifications, regulatory documents, Design History File) is specified and within LABS's control, and could conclusively prove assertions (a) and (b)

    KlägerRechtsgrundlage: Art. 59 UPCA; R.190 RoP
  • Confidentiality is adequately protected by limiting access to legal team, independent experts, and one employee subject to non-disclosure obligations

    KlägerRechtsgrundlage: R.262A RoP
  • Regulatory framework (Medical Device Directive / Medical Device Regulation) requires LABS to retain relevant technical and certification documents for 15 years, so such documents should exist

    KlägerRechtsgrundlage: Council Directive 93/42/EEC; EU Regulation 2017/745; ISO 13485:2016
Zurückgewiesene Argumente
Was das Gericht nicht akzeptiert hat — und warum.
  • Post-priority physical samples (request I.c) are necessary because pre-priority samples held by Defendants may be argued by LABS as non-representative or degraded

    KlägerRechtsgrundlage: R.190 RoP
  • Application is premature, circumvents the procedural framework, and is disproportionate at this stage of proceedings before the Reply to Defence has been filed

    BeklagterRechtsgrundlage: Art. 59 UPCA; R.190 RoP; general principles of proportionality and fairness
  • The requests are too broadly defined and producing all versions in all languages of marketing/technical documents would be disproportionate

    BeklagterRechtsgrundlage: R.190 RoP; proportionality principle
  • Simply asserting that documents are confidential and internal is sufficient grounds to deny the production request

    BeklagterRechtsgrundlage: R.262A RoP